Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease

INTRODUCTION: Hyperparathyroidism (SHPT) secondary to chronic kidney disease (CKD) is characterized by high levels of parathyroid hormone (PTH), hyperplasia of the parathyroid glands and cardiovascular disease. Selective and non-selective and selective vitamin D-receptor activators, calcimimetics, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Marilia Mastrocolla de Almeida, Machado-Rugolo, Juliana, Lima, Silvana Andrea Molina, de Andrade, Luis Gustavo Modelli, Curado, Daniel da Silva Pereira, Ponce, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2022
Materias:
Perspectives/Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139708/
https://www.ncbi.nlm.nih.gov/pubmed/35980102
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0049en

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139708/
https://www.ncbi.nlm.nih.gov/pubmed/35980102
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0049en

Ejemplares similares